Leaderboard
Popular Content
Showing content with the highest reputation on 05/21/21 in all areas
-
Ngayun pa lang actually naiiyak na ako... Hindi dahil sa baka maubusan ako ng vaccine... Nakakaiyak kung papano ka mag isip 😄 Ikaw tong nag rereklamo at ayaw mag pa vaccine, eh di ikaw rin ang unang iiyak sa pinag iisip mong vaccine pass HAHAHAHA!3 points
-
I wonder if spas are open now and how safe it is to go to one. I need a total relaxation day. I need a mani/pedi, body scrub, wax and a massage. Probably facial cleaning and diamond peel too. And a haircut. Then some good food after. I wonder if gyms are also open now. Grasping for some sense of normalcy here.1 point
-
its a risk we have to take, syempre with added prayers na din. problem sa gustong mag abroad, like here in kuwait they chose 4 vaccines lng na iaccept nila makalabas at makapsok ulit. funny is before sinovac recommended nila now its down to 1. pfizer 2.astrazenecca 3. moderna 4. johnson and jonhson which is companies na to are handled by some rich locals kaya yan push nila. and balita di nagkasundo sa chinese vaccine not sure kung price or number of vaccines.1 point
-
agree, gusto ko n din magbakasyon sa pinas, miss ko n lupang sinilangan, kahit magulo dyan naman tyo lumaki1 point
-
Netflix had launched a documentary series called Worn Stories that featured people's meaningful pieces of clothing that were part of some very interesting event in their lives - bad and good. Filipinos are very sentimental when it comes to things that gave meaning in their lives. It can be a watch, a pair of canvas shoes, a worn out buckle of a belt or a faded tote. You need to take a picture of it or you can steal a photo on Google and write what's your sentimental memory, good or bad, sad or mad!1 point
-
All those days watching from the windows All those years outside looking in All that time never even knowing Just how blind I've been Now I'm here blinking in the starlight Now I'm here suddenly I see Standing here it's all so clear I'm where I'm meant to be And at last I see the light And it's like the fog has lifted And at last I see the light And it's like the sky is new And it's warm and real and bright And the world has somehow shifted All at once everything looks different Now that I see you All those days chasing down a daydream All those years living in a blur All that time never truly seeing Things, the way they were Now she's here shining in the starlight Now she's here suddenly I know If she's here it's crystal clear I'm where I'm meant to go And at last I see the light And it's like the fog has lifted And at last I see the light And it's like the sky is new And it's warm and real and bright And the world has somehow shifted All at once everything is different Now that I see you Now that I see you1 point
-
You have a beautiful mind, Nightwriter. I'm writing a letter to Elon, to clone your mind, to send to Mars.1 point
-
Ang buong mundo e pinaluhod ng covid 19. Alam mo ba na sa lahat ng mga bansa sa buong mundo e ang daming mga matatalinong tao na pinag aralan nila ang virus na ito. Ang sinasabi mo e mas matalino ka pa sa kanilang lahat dahil naloko sila ng covid. Ano ba ebidensya mo na hysteria lang ang nangyayari? Kung sinabi ko sa yo na gawa gawa lang ito ni Mickey Mouse, maniwala ka ba? Yung only few na sinasabi e mukang sila ang bobo.. Gising na walang utak.1 point
-
1 point
-
Why are you against getting vaccinated? It is not discrimination, it is basic safety measures. Millions have been infected. India is struggling. Our economy is struggling. The faster we beat thia virus, the faster we all get back to our normal lives. And if getting vaccinated keeps me from possibly spreading the virus, then i'd do it. The virus doesnt discriminate. The safety protocols are for everyone. We are not trampling on anyone's rights. We are protecting everybody. If the act of wearing a face mask prevents me from getting infected and infecting my loved ones, i'll do it. I respect human life. Even if I find wearing face shields stifling and getting a vaccine risky. I will do it. To protect the ones i love. People I know have been infected. Friends and acquaintances suffered. Family of friends have died. Wear your mask, maintain distance and get the vaccine.1 point
-
How can i have a rational conversation with someone who sees discrimination everywhere even the most reasoned and thoughtful statement? I can imagine why you would feel what I said was discrimination. But I see nothing to apologize for. Anyway, I’m encouraging more people to get theirs. Who knows what the future holds for the rest of us. I honestly don’t want to be injected with anti-bodies in my system. Numbers of people are dying to this day and I just want to stop wearing masks anymore!1 point
-
I’ve taken the Moderna vaccine a month ago and on to my second in June. To be honest, I wasn’t exactly thrilled of the prospect of getting it because I’ve been on the plane since the pandemic and shutdown began. I didn’t feel funny or sick but I realized that it’s important that we have to encourage people in getting the vaccine and to save other people’s lives. We can endanger other people’s lives by being a vessel of Covid. It sound dramatic but it’s reality. If people choose not to get vaccinated then they’re fully responsible of what happens to their family, relatives and friends. If people are still convinced that Covid didn’t have an impact in India - God help us! 😢1 point
-
1 point
-
Congratulations to everyone who got vaxxed! Thank you also for posting and sharing your personal experiences. Let's hope this chapter of our lives will be over soon. Kakapagod na!1 point
-
1 point
-
1 point
-
Thank you very much. My mind was on hyperdrive when I made the post though. Working and thinking and posting and thinking and writing. 😀1 point
-
1 point
-
Dear Kat, I love your posts a lot. This one just put sicks in my eyelids, somehow I managed not to blink from start to finish.1 point
-
A pair of All Stars Adidas ( Not my shoe on pic but similar) I was 18 years old and barely knew how to tie shoelaces. I figured if I'd buy a pair of adidas, my date would like me. he's nuts on sneakers and I'm not the type of girl who does but I would for just the day. It was raining in UP Diliiman on a friday afternoon when I hopped down from the Jeepney across the building where he's studying his Masters. I lived for quite long ways to see him and he offered to drive me back home after our date. I huddled towards the waiting area with a couple of students waiting for the next jeepney. I took my phone out of my bag and sent a text to Diego where I am. As I was waiting, I looked towards my feet and my laces were untied. I was fuzzing over white laces drenched with brown mud and I still couldn't do it. It was only when he came to pick me up that I yelled that I'm stuck with the f*kin shoe laces that he parked and rushed towards me. He gave me the look - the KUYA look ( the look that makes you feel 'inis' and loathing).and bent his knees and started to tie the laces. We rushed into his car and he drove quickly as he can so the people can go inside the jeepney. I was horrified that he learned my secret, I felt exposed and He didn't mind for one bit that I can't. We went to our usual stuff - eating in a burger joint and talking about school and work and drive home. That pair of shoes walked a thousand rides to UP Diliman and numerous strolls in the Sunken Gardens that it worn me out. I guess I got tired waiting under overpasses and School buildings. When a relationship is limited to someone else's time and you can't go around it - it's time pick up a new pair and move on. I kept the shoes though and still couldn't tie any better.1 point
-
1 point
-
1 point
-
1 point
-
Novavax, a late-stage US biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. This Maryland company is smaller compared to other vaccine manufacturers. They received a $1.6 billion grant from the US government’s Operation Warp Speed to produce 100 million doses by 2021. How their vaccines work: According to an article published in the Science Magazine, a peer-reviewed academic journal of the American Association for the Advancement of Science, Novavax first inserts baculovirus into moth cells. The baculovirus, a pathogen that attacks insects, will make moth cells produce a protein called spike – which is present in coronavirus. The spikes are then harvested by scientists and mixed with a “synthetic soap like particle” where the spikes can latch on. A compound called saponin, also derived from plants and trees, is also added to boost the immune response. The NVX‑CoV2373 vaccine aims to produce anti spike antibodies that can block SARS-CoV-2 infection. Status development: As of November 30, Novavax said in a statement that it has completed the enrollment of its 15,000-patient UK Phase 3 trial. The company added that has fully enrolled the Phase 2b trial in South Africa. “Novavax expects its pivotal Phase 3 clinical trial in the United States and Mexico to begin in the coming weeks. More than 100 trial sites have been selected with some alternate sites in place, should they be needed,” the company added. Roll-out: Since the vaccine is still in its early trial stages, there is still no expected release date.1 point
-
AstraZeneca is a British-Swedish multinational pharmaceutical and biopharmaceutical company that focuses on the development and commercialization of prescription medicine. Their medicines are targeted for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases. AstraZeneca collaborated with the University of Oxford to create a COVID-19 vaccine. How their vaccine works: Like Russia’s Sputnik V, AstraZeneca’s vaccines use a genetically altered virus called adenovirus. This virus, which is not harmful to recipients, will carry spike protein (like the “crowns” in coronavirus). Injecting this, in theory, will help the immune system to recognize and attack coronavirus. AstraZeneca’s vaccine requires a regular fridge temperature for storage. Status development: AstraZeneca and the University of Oxford announced on December 8 that it finished the Phase 3 interim analysis for the vaccine. The researchers noted that the efficacy rate for two doses – with the first dose at half strength – reached 90 percent. While a combination of two full-strength doses only resulted in 62 percent efficacy. Issues and concerns: Scientists questioned the vaccine efficacy rate after the reported error in dosage. In a report published by the New York Times on November 25, experts inquired how the combination of half dosage for the first shot and full dosage for the second shot resulted in a 90 percent efficacy rate.1 point
-
COVAX Facility, also known as the COVID-19 Vaccines Global Acces Facility, is a global mechanism designed to guarantee rapid, fair, and equitable access to COVID-19 vaccines worldwide. It is co-led by Gavi, an international organization created to improve access to new and underused vaccines, along with the Coalition for Epidemic Preparedness Innovations and the World Health Organization. The Philippines joined COVAX Facility in July. How does COVAX Facility work? “The COVAX Facility will make investments across a broad portfolio of promising vaccine candidates (including those being supported by CEPI) to make sure at-risk investment in manufacturing happens now,” Gavi explained. Since it follows a pooling process, COVAX can ensure rapid access to vaccines. Status about COVID-19 vaccine: According to the Philippines’ vaccine czar Galvez, about 80 percent of the vaccines in the global market were already taken by rich countries. The COVAX Facility, on the other hand, was able to acquire 2 percent. This means that the country is “fighting” to secure the other 18 percent of the vaccine supply.1 point
-
The Gamelaya Research Institute of Epidemiology and Microbiology is a Russian medical-research institute founded in 1891. According to Gamelaya, it “runs one of the unique “virus libraries” in the world and has its own vaccine production facility.” Aside from their research for the COVID-19 vaccine, they are also working to develop a vaccine against Ebola and the Middle East Respiratory Syndrome (MERS). How their vaccine works: Sputnik V is a two-part adenovirus-based vector vaccine. It uses a vector (an engineered virus that lacks the gene to reproduce) to send a message in cells to produce spike proteins. “The gene from adenovirus, which causes the infection, is removed while a gene with the code of a protein from another virus spike is inserted,” the institute explained. “This inserted element is safe for the body but still helps the immune system to react and produce antibodies, which protect us from the infection,” it added. Sputnik V is stored in a regular refrigerator temperature (in dry form). Status development: Gamaleya on November 24 announced that it has finished the second interim analysis of clinical trial data for Sputnik V. “The Sputnik V vaccine’s efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials. The Sputnik V vaccine efficacy against severe cases of coronavirus is 100%,” Gamaleya reported. In October, the Russian Direct Investment Fund (RDIF) submitted applications to the World Health Organization for an Emergency Use Listing and prequalification of Sputnik V. According to a report on Monday, Russia is almost done completing its clinical trials for its COVID-19 vaccine for domestic animals and mink. Issues and concerns: Some scientists have recently expressed concerns towards Sputnik V due to a “lack of safety data.” However, Russia denounced the criticisms.1 point
-
US-based multinational pharmaceutical corporation, Pfizer, is also known as one of the world’s largest pharmaceutical companies. On the other hand, BioNTech SE is a German biotechnology company that focuses on individualized immunotherapies. How their vaccine works: Pfizer-BioNTech’s vaccine is similar to Moderna’s mRNA-1273 in the sense that it uses mRNA to eliminate the new coronavirus SARS-CoV-2. Pfizer-BioNTech’s vaccine requires storage with a temperature of -70 degrees Celsius. Status development: Pfizer and BioNTech concluded the Phase 3 study for their vaccine on November 18. Meanwhile, the USFDA on December 12 granted an emergency use authorization for the vaccine, and on December 14 started its use in New York City. The United Kingdom, the first country in the world to conduct mass inoculation against COVID-19 starting December 8, likewise used the vaccine developed by Pfizer and BioNTech. On Monday, Singapore Prime Minister Lee Hsien Long announced the approval of the Pfizer-BioNTech vaccine for his country’s mass vaccination program that will likely begin by end-December. Later, Jordan announced it had approved emergency use of the Pfizer-BioNTech coronavirus vaccine. Pfizer’s vaccine showed a 95 percent efficacy rate during its study. Issues and concerns: U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA) on December 10 issued an anaphylaxis warning on the Pfizer-BioNTech vaccine after reports of three cases of adverse reactions. According to MHRA, there were two reports of anaphylaxis and one possible allergic reaction after administering the vaccines. “Any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer BioNTech vaccine,” MHRA Chief Executive June Raine said in a statement. “Most people will not get anaphylaxis and the benefits in protecting people against COVID-19 outweigh the risks… You can be completely confident that this vaccine has met the MHRA’s robust standards of safety, quality and effectiveness,” Raine assured. Roll-out: Pfizer-BioNTech began its first shipment of the vaccines to several states in America on December 13.1 point
-
Sinovac is a Beijing-based biopharmaceutical company founded in 2001. Their focus is on the research, development, and manufacture of vaccines against infectious diseases such as H1N1 influenza and COVID-19. How their vaccine works: Unlike Moderna, which uses RNA in its vaccines, Sinovac’s CoronaVac relies on inactivated pathogens that are grown and killed in laboratories. Similar to the inactivated vaccines used for polio, this vaccine uses the killed viruses to produce antigens which signal the immune system to attack the virus causing COVID-19. CoronaVac can be stored in a standard refrigerator at 2-8 degrees Celsius. Status development: In October, Sinovac submitted its application to the Food and Drug Administration (FDA) of the Philippines to conduct Phase 3 clinical trials for CoronaVac in the country. COVID-19 policy chief implementer and vaccine czar Carlito Galvez, Jr. earlier said that the vaccine may be the first to be rolled out in the country, probably by the first quarter of 2021. Sinovac has yet to report the efficacy rate of CoronaVac. Issues and concerns: Sinovac has been recently reported to be involved in a bribery scandal. However, the company cleared out its CEO, Yin Weidong, of the accusations. Roll-out: According to Galvez, they are already finalizing negotiations with Sinovac. He said the pharmaceutical firm vowed to supply vaccines in the country by April 2021. However, Galvez negotiated to get it by March.1 point
-
Moderna is a Massachusetts-based biotechnology company that focuses on drug discovery and development. It also makes vaccines based on mRNA. How their vaccine works: The Centers for Disease Control and Prevention (CDC) website said the vaccine, also known as “mRNA-1273,” basically uses mRNA, a genetic molecule that carries the instructions for making proteins in our body. This vaccine requires two shots that will be given 28 days apart. The mRNA in the vaccine will instruct cells to make a harmless spike protein – which can also be seen on the surface of SARS-CoV-2, the new strain of coronavirus that causes respiratory disease COVID-19, said the CDC website. According to the CDC, the protruding spikes and spike fragments in the cell will then be recognized by the immune system and cause an immune response that produces antibodies. These antibodies stop the coronavirus from attacking other cells by attaching to the virus’s spikes. The antibodies can also mark the virus so other cells can detect and destroy it. Moderna’s vaccine needs to be stored at -20C. Status development: Moderna announced last month that it has finished the first interim analysis of the Phase 3 study for mRNA-1273. According to the company, the study showed that its vaccine has an efficacy rate of 94.5 percent. Issues and concerns: Based on a study published in The New England Journal of Medicine, Moderna’s vaccine can protect for at least three months. But according to a report by the New York Times, since the vaccine is new, researchers still have no idea how long the vaccine’s protection will last. The report added that the number of antibodies and T-cells might reduce months after the vaccination. However, memory B-cells and memory-T cells might retain the information about the coronavirus even after years or decades. Roll-out: Moderna applied for emergency use authorization to the U.S. Food and Drug Administration (USFDA) on November 30. USFDA is set to decide on its application on December 17. If approved, Moderna can start releasing its vaccines in the US before the end of the month.1 point
-
I disagree on this part. Its more of a discriminatory remark for me.-1 points
-
Okay, ganito na lang. Pag naubusan kayo vaccine, tapos nag implement ng mga vaccine pass sa lahat ng establishments pati sa abroad, wag kayo mag iiyak ah.-1 points